In the past week, ACLX stock has gone down by -9.89%, with a monthly gain of 15.29% and a quarterly surge of 39.31%. The volatility ratio for the week is 4.74%, and the volatility levels for the last 30 days are 4.51% for Arcellx Inc The simple moving average for the past 20 days is -3.26% for ACLX’s stock, with a 24.71% simple moving average for the past 200 days.
Is It Worth Investing in Arcellx Inc (NASDAQ: ACLX) Right Now?
ACLX has 36-month beta value of 0.27. Analysts have mixed views on the stock, with 11 analysts rating it as a “buy,” 6 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ACLX is 40.36M, and currently, short sellers hold a 11.77% ratio of that float. The average trading volume of ACLX on October 03, 2024 was 451.13K shares.
ACLX) stock’s latest price update
Arcellx Inc (NASDAQ: ACLX) has experienced a decline in its stock price by -6.40 compared to its previous closing price of 81.44. However, the company has seen a fall of -9.89% in its stock price over the last five trading days. seekingalpha.com reported 2024-09-10 that Arcellx leverages proprietary platforms like D-Domain, ddCAR, and ARC-SparX to enhance immune response, targeting multiple myeloma, AML, MDS, and solid tumors. ACLX’s lead therapy, anito-cel, shows strong clinical results in relapsed/refractory multiple myeloma, even for high-risk patients. Arcellx’s strategic partnership with Kite Pharma validates its technology, potentially leading to milestone payments of up to $935 million.
Analysts’ Opinion of ACLX
Piper Sandler, on the other hand, stated in their research note that they expect to see ACLX reach a price target of $70. The rating they have provided for ACLX stocks is “Overweight” according to the report published on May 31st, 2024.
Morgan Stanley gave a rating of “Overweight” to ACLX, setting the target price at $81 in the report published on March 07th of the current year.
ACLX Trading at 10.38% from the 50-Day Moving Average
After a stumble in the market that brought ACLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.02% of loss for the given period.
Volatility was left at 4.51%, however, over the last 30 days, the volatility rate increased by 4.74%, as shares surge +16.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.69% upper at present.
During the last 5 trading sessions, ACLX fell by -9.89%, which changed the moving average for the period of 200-days by +48.60% in comparison to the 20-day moving average, which settled at $79.34. In addition, Arcellx Inc saw 37.35% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACLX starting from Gilson Michelle, who sale 15,000 shares at the price of $77.73 back on Sep 17 ’24. After this action, Gilson Michelle now owns 6,915 shares of Arcellx Inc, valued at $1,165,880 using the latest closing price.
MICHELLE GILSON, the Officer of Arcellx Inc, proposed sale 15,000 shares at $77.01 during a trade that took place back on Sep 17 ’24, which means that MICHELLE GILSON is holding shares at $1,155,150 based on the most recent closing price.
Stock Fundamentals for ACLX
Current profitability levels for the company are sitting at:
- -0.56 for the present operating margin
- 0.98 for the gross margin
The net margin for Arcellx Inc stands at -0.37. The total capital return value is set at -0.12. Equity return is now at value -13.80, with -7.94 for asset returns.
Based on Arcellx Inc (ACLX), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -0.27. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -87.02.
Currently, EBITDA for the company is -87.84 million with net debt to EBITDA at 0.33. When we switch over and look at the enterprise to sales, we see a ratio of 28.13. The receivables turnover for the company is 45.23for trailing twelve months and the total asset turnover is 0.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.01.
Conclusion
To put it simply, Arcellx Inc (ACLX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
